NewKerala.com

Key Points

The Technology Development Board has announced financial support for S3V Vascular Technologies' project to develop India’s first indigenous thrombectomy device for stroke care. This initiative will take place in a new manufacturing facility at Chennai's Medical Devices Park, aiming to reduce reliance on expensive imports and make stroke treatment more affordable. The innovation aligns with the goals of the Ayushman Bharat scheme, focusing on inclusive healthcare access. With plans for global regulatory approvals, S3V seeks to expand the availability of advanced stroke care solutions worldwide.

Key Points: Govt Supports India's First Indigenous Stroke Device by S3V

  • TDB funds S3V's stroke device plant in Chennai
  • Indigenous thrombectomy kit set to enhance stroke care
  • Project aligns with Ayushman Bharat for inclusive healthcare access
2 min read

Govt to aid development of India's 1st indigenous thrombectomy device for stroke care

Technology Development Board backs S3V's stroke device, enhancing affordable care with indigenous innovation.

"The TDB is proud to support S3V’s vision of building India’s first comprehensive neuro-intervention manufacturing ecosystem. - Rajesh Kumar Pathak"

New Delhi, May 30

In a significant boost to India's medtech innovation landscape, the Technology Development Board (TDB), under the Union Department of Science and Technology (DST), on Friday announced financial support to the development of India’s first indigenous thrombectomy device for stroke care.

The board sanctioned assistance to Mysuru-based S3V Vascular Technologies’ pioneering neuro-intervention integrated manufacturing plant for the treatment of stroke, which sees nearly 1.5 million cases every year in the country.

The project envisions the establishment of a state-of-the-art upstream integrated manufacturing facility at the Medical Devices Park, Oragadam in Chennai’s Sriperumbudur.

The plant will develop and manufacture advanced mechanical thrombectomy kits -- a life-saving intervention for patients suffering from acute ischemic stroke due to large vessel occlusion.

Compared to conventional thrombolysis, thrombectomy offers significantly improved outcomes, reducing the risk of long-term paralysis and disability.

"The TDB is proud to support S3V’s vision of building India’s first comprehensive neuro-intervention manufacturing ecosystem. This project reflects our continued commitment to making India a global hub for affordable, high-end medical technology -- especially in areas of critical public health needs like stroke care," TDB Secretary Rajesh Kumar Pathak said.

"The company’s focus on integrating these devices into Ayushman Bharat further aligns with the national goal of inclusive healthcare access," he added.

The initiative will help replace expensive imported devices with high-quality, locally manufactured alternatives, enhancing both the affordability and accessibility of stroke care in India.

"Our integrated manufacturing facility will not only reduce dependency on imports of the finished medical devices used in Mechanical Thrombectomy but also reduces India's dependency on import of the raw materials used in manufacturing of these critical complex lifesaving medical devices," S3V Vascular Technologies Managing Director, Dr N.G. Vijaya Gopal, said, while lauding the government for its support.

Gopal said the company has already initiated the CE and the US FDA approval process for the devices to expand access to cutting-edge stroke care solutions across India, Asia, Latin America, Europe, and the US.

- IANS

Share this article:

Reader Comments

P
Priya K.
This is such a proud moment for Indian healthcare innovation! 🇮🇳 Reducing dependency on imported medical devices while making stroke care more affordable is exactly what our country needs. Hope this inspires more startups in the medtech space.
R
Rahul S.
Great initiative, but I hope the government ensures these devices reach rural areas too. Often such advanced treatments remain limited to metro cities. Ayushman Bharat integration is a good step though.
A
Ananya M.
My grandfather suffered a stroke last year and we had to pay lakhs for treatment. If this device can reduce costs, it will be a blessing for middle-class families. Kudos to the team working on this project! 🙏
V
Vikram P.
Interesting to see Mysuru-based company getting support. We need more regional hubs for medtech beyond Bangalore/Hyderabad. Hope the Chennai facility creates good employment opportunities locally.
S
Sanjay T.
While this is commendable, I hope quality isn't compromised in the rush for 'Make in India'. Medical devices need strict quality control - we've seen issues with some indigenous products in past.
N
Neha R.
As a medical student, I'm thrilled! We study about these advanced procedures but often don't get to practice them due to cost barriers. Maybe now more hospitals can offer thrombectomy training. 🤞
K
Karthik D.
Targeting CE and US FDA approval shows ambition! If successful, this could position India as medtech exporter rather than just import-dependent nation. More such projects needed in other critical care areas too.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50